Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Avacta Group plc
Life Sciences
Bringing forward the Affimer technology
By
Dr Martin Hall
05 May 2017
Avacta Group plc
Life Sciences
Another important box ticked
By
Dr Martin Hall
12 Apr 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Redx Pharma
Life Sciences
CARB-X – new strategic collaboration
By
Dr Martin Hall
03 Apr 2017
Oxford BioMedica
Life Sciences
Initiation: Delivering commercial gene-therapy vector
31 Mar 2017
Diurnal Group Plc
Life Sciences
Commercial and development progresses
By
Dr Martin Hall
27 Mar 2017
Avacta Group plc
Life Sciences
Low response would be positive!
21 Mar 2017
Advanced Oncotherapy
Life Sciences
Delivery of LIGHT
By
Dr Martin Hall
15 Mar 2017
Tissue Regenix
Life Sciences
Addressing woundcare in the US
13 Mar 2017
Collagen Solutions Plc
Life Sciences
Engineering cartilage repairs
By
Dr Martin Hall
13 Mar 2017
Collagen Solutions Plc
Life Sciences
Capital increase to support accelerated growth
By
Dr Martin Hall
14 Feb 2017
Allergy Therapeutics plc
Life Sciences
Disruptive peanut allergy vaccine
By
Dr Martin Hall
13 Feb 2017
Prev
1
...
19
20
21
22
Next
